| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 180 | 2022 |
| Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection J Shi, J Fan, R Wu, X Gao, L Zhang, H Wang, GC Farrell Journal of gastroenterology and hepatology 23 (9), 1419-1425, 2008 | 180 | 2008 |
| Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2 D Ye, K Yang, S Zang, Z Lin, HT Chau, Y Wang, J Zhang, J Shi, A Xu, ... Journal of Hepatology 65 (5), 988-997, 2016 | 167 | 2016 |
| Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway M Li, C Xu, J Shi, J Ding, X Wan, D Chen, J Gao, C Li, J Zhang, Y Lin, Z Tu, ... Gut 67 (12), 2169-2180, 2018 | 135 | 2018 |
| Lactylation, a novel metabolic reprogramming code: current status and prospects AN Chen, Y Luo, YH Yang, JT Fu, XM Geng, JP Shi, J Yang Frontiers in immunology 12, 688910, 2021 | 130 | 2021 |
| ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population J Wang, C Xu, Y Xun, Z Lu, J Shi, C Yu, Y Li Scientific reports 5 (1), 16494, 2015 | 114 | 2015 |
| The 104‐week efficacy and safety of telbivudine‐based optimization strategy in chronic hepatitis B patients: a randomized, controlled study J Sun, Q Xie, D Tan, Q Ning, J Niu, X Bai, R Fan, S Chen, J Cheng, Y Yu, ... Hepatology 59 (4), 1283-1292, 2014 | 114 | 2014 |
| Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease F Shen, RD Zheng, JP Shi, YQ Mi, GF Chen, X Hu, YG Liu, XY Wang, ... Liver International 35 (11), 2392-2400, 2015 | 113 | 2015 |
| From NAFLD to MAFLD: a" redefining" moment for fatty liver disease KI Zheng, JG Fan, JP Shi, VWS Wong, M Eslam, J George, MH Zheng Chinese medical journal 133 (19), 2271-2273, 2020 | 111 | 2020 |
| Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). JG Fan, L Wei, H Zhuang, W Cai, D Feng Chen, ZP Duan, X Gao, T Han, ... Journal of Digestive Diseases 20 (4), 2019 | 110 | 2019 |
| Toll‐like receptor‐4 signalling in the progression of non‐alcoholic fatty liver disease induced by high‐fat and high‐fructose diet in mice J Liu, Z Zhuang, D Bian, X Ma, Y Xun, W Yang, Y Luo, Y Liu, L Jia, ... Clinical and Experimental Pharmacology and Physiology 41 (7), 482-488, 2014 | 90 | 2014 |
| Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice Y Luo, G Tian, Z Zhuang, J Chen, N You, L Zhuo, B Liang, Y Song, S Zang, ... American journal of translational research 11 (5), 2668, 2019 | 77 | 2019 |
| Curcumin: a promising agent targeting cancer stem cells S Zang, T Liu, J Shi, L Qiao Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2014 | 70 | 2014 |
| Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose Y Han, JP Shi, AL Ma, Y Xu, XD Ding, JG Fan Clinical drug investigation 34, 1-7, 2014 | 68 | 2014 |
| Neutrophils play a crucial role in the early stage of nonalcoholic steatohepatitis via neutrophil elastase in mice S Zang, L Wang, X Ma, G Zhu, Z Zhuang, Y Xun, F Zhao, W Yang, J Liu, ... Cell biochemistry and biophysics 73, 479-487, 2015 | 63 | 2015 |
| Relationship of serum uric acid level with non‐alcoholic fatty liver disease and its inflammation progression in non‐obese adults J Liu, C Xu, L Ying, S Zang, Z Zhuang, H Lv, W Yang, Y Luo, X Ma, ... Hepatology Research 47 (3), E104-E112, 2017 | 60 | 2017 |
| AKT/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells L Gong, C Di, X Xia, J Wang, G Chen, J Shi, P Chen, H Xu, W Zhang International Journal of Oncology 49 (6), 2538-2548, 2016 | 58 | 2016 |
| Characterization of transcriptional modules related to fibrosing-NAFLD progression Y Lou, GY Tian, Y Song, YL Liu, YD Chen, JP Shi, J Yang Scientific reports 7 (1), 4748, 2017 | 54 | 2017 |
| Suboptimal performance of simple noninvasive tests for advanced fibrosis in C hinese patients with nonalcoholic fatty liver disease YH Xun, JG Fan, GQ Zang, H Liu, YM Jiang, J Xiang, Q Huang, JP Shi Journal of digestive diseases 13 (11), 588-595, 2012 | 49 | 2012 |
| Meta‐analysis: global prevalence, trend and forecasting of non‐alcoholic fatty liver disease in children and adolescents, 2000–2021 J Li, A Ha, F Rui, B Zou, H Yang, Q Xue, X Hu, Y Xu, L Henry, M Barakat, ... Alimentary Pharmacology & Therapeutics 56 (3), 396-406, 2022 | 44 | 2022 |
jiangao fanxinhua hospital affiliated to shanghai jiaotong university school of medicine在 xinhuamed.com.cn 的电子邮件经过验证
jiangao fanxinhua hospital affiliated to shanghai jiaotong university school of medicine在 xinhuamed.com.cn 的电子邮件经过验证
Liang QiaoThe University of Sydney在 sydney.edu.au 的电子邮件经过验证